G108

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 533079

CAS#: 2369750-66-1

Description: G108 is a Novel h-cGAS specific inhibitor for repression of dsDNA-triggered interferon expression (IC50 of 27.5 nM and 5150 nM for h-cGAS and m-cGAS, respectively).


Chemical Structure

img
G108
CAS# 2369750-66-1

Theoretical Analysis

MedKoo Cat#: 533079
Name: G108
CAS#: 2369750-66-1
Chemical Formula: C16H14Cl2N4O2
Exact Mass: 364.05
Molecular Weight: 365.214
Elemental Analysis: C, 52.62; H, 3.86; Cl, 19.41; N, 15.34; O, 8.76

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: G108; G-108; G 108

IUPAC/Chemical Name: 1-(6,7-Dichloro-9-(1H-pyrazol-4-yl)-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indol-2-yl)-2-hydroxyethan-1-one

InChi Key: UUDFSTGSYHGEEV-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H14Cl2N4O2/c17-11-3-9(8-4-19-20-5-8)14-10-6-22(13(24)7-23)2-1-12(10)21-16(14)15(11)18/h3-5,21,23H,1-2,6-7H2,(H,19,20)

SMILES Code: O=C(N(C1)CCC(N2)=C1C3=C2C(Cl)=C(Cl)C=C3C4=CNN=C4)CO

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 365.21 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Dziadek M, Kudlackova R, Zima A, Slosarczyk A, Ziabka M, Jelen P, Shkarina S,
Cecilia A, Zuber M, Baumbach T, Surmeneva MA, Surmenev RA, Bacakova L,
Cholewa-Kowalska K, Douglas TEL. Novel multicomponent organic-inorganic
WPI/gelatin/CaP hydrogel composites for bone tissue engineering. J Biomed Mater
Res A. 2019 Nov;107(11):2479-2491. doi: 10.1002/jbm.a.36754. Epub 2019 Jul 22.
PubMed PMID: 31298796.


2: Cao Y, Xiao Y, Zhou K, Yan J, Wang P, Yan W, Cai W. FXR agonist GW4064
improves liver and intestinal pathology and alters bile acid metabolism in rats
undergoing small intestinal resection. Am J Physiol Gastrointest Liver Physiol.
2019 Aug 1;317(2):G108-G115. doi: 10.1152/ajpgi.00356.2017. Epub 2019 Mar 28.
PubMed PMID: 30920307.


3: Teixeira VH, Pipinikas CP, Pennycuick A, Lee-Six H, Chandrasekharan D, Beane
J, Morris TJ, Karpathakis A, Feber A, Breeze CE, Ntolios P, Hynds RE, Falzon M,
Capitanio A, Carroll B, Durrenberger PF, Hardavella G, Brown JM, Lynch AG,
Farmery H, Paul DS, Chambers RC, McGranahan N, Navani N, Thakrar RM, Swanton C,
Beck S, George PJ, Spira A, Campbell PJ, Thirlwell C, Janes SM. Deciphering the
genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer
lesions. Nat Med. 2019 Mar;25(3):517-525. doi: 10.1038/s41591-018-0323-0. Epub
2019 Jan 21. PubMed PMID: 30664780.


4: Pariante CM. The year of immunopsychiatry: A special issue that foresaw the
future. Psychoneuroendocrinology. 2019 May;103:49-51. doi:
10.1016/j.psyneuen.2019.01.002. Epub 2019 Jan 7. PubMed PMID: 30640037.


5: Green S, Reivonen S, Rutter LM, Nouzova E, Duncan N, Clarke C, MacLullich AMJ,
Tieges Z. Investigating speech and language impairments in delirium: A
preliminary case-control study. PLoS One. 2018 Nov 26;13(11):e0207527. doi:
10.1371/journal.pone.0207527. eCollection 2018. PubMed PMID: 30475831; PubMed
Central PMCID: PMC6261049.


6: Gibson LM, Paul L, Chappell FM, Macleod M, Whiteley WN, Al-Shahi Salman R,
Wardlaw JM, Sudlow CLM. Potentially serious incidental findings on brain and body
magnetic resonance imaging of apparently asymptomatic adults: systematic review
and meta-analysis. BMJ. 2018 Nov 22;363:k4577. doi: 10.1136/bmj.k4577. PubMed
PMID: 30467245; PubMed Central PMCID: PMC6249611.


7: Hynds RE, Vladimirou E, Janes SM. The secret lives of cancer cell lines. Dis
Model Mech. 2018 Nov 16;11(11). pii: dmm037366. doi: 10.1242/dmm.037366. PubMed
PMID: 30459183; PubMed Central PMCID: PMC6262811.


8: Cajzl J, Nekvindová P, Macková A, Malinský P, Oswald J, Remeš Z, Varga M,
Kromka A, Akhetova B, Böttger R, Prajzler V. Erbium Luminescence Centres in
Single- and Nano-Crystalline Diamond-Effects of Ion Implantation Fluence and
Thermal Annealing. Micromachines (Basel). 2018 Jun 22;9(7). pii: E316. doi:
10.3390/mi9070316. PubMed PMID: 30424249; PubMed Central PMCID: PMC6082296.


9: Rutter LM, Nouzova E, Stott DJ, Weir CJ, Assi V, Barnett JH, Clarke C, Duncan
N, Evans J, Green S, Hendry K, McGinlay M, McKeever J, Middleton DG, Parks S,
Shaw R, Tang E, Walsh T, Weir AJ, Wilson E, Quasim T, MacLullich AMJ, Tieges Z.
Diagnostic test accuracy of a novel smartphone application for the assessment of
attention deficits in delirium in older hospitalised patients: a prospective
cohort study protocol. BMC Geriatr. 2018 Sep 17;18(1):217. doi:
10.1186/s12877-018-0901-5. PubMed PMID: 30223771; PubMed Central PMCID:
PMC6142423.


10: Tang E, Laverty M, Weir A, Wilson ES, Walsh TS, Allerhand M, Parks S,
MacLullich AMJ, Tieges Z. Development and feasibility of a smartphone-based test
for the objective detection and monitoring of attention impairments in delirium
in the ICU. J Crit Care. 2018 Dec;48:104-111. doi: 10.1016/j.jcrc.2018.08.019.
Epub 2018 Aug 21. PubMed PMID: 30176525.


11: Reynolds CJ, Quigley K, Cheng X, Suresh A, Tahir S, Ahmed-Jushuf F, Nawab K,
Choy K, Walker SA, Mathie SA, Sim M, Stowell J, Manji J, Pollard T, Altmann DM,
Boyton RJ. Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling
and Impaired Function. Am J Respir Cell Mol Biol. 2018 Nov;59(5):557-571. doi:
10.1165/rcmb.2018-0007OC. PubMed PMID: 29894204; PubMed Central PMCID:
PMC6236688.


12: McGinnity CJ, Riaño Barros DA, Trigg W, Brooks DJ, Hinz R, Duncan JS, Koepp
MJ, Hammers A. Simplifying [(18)F]GE-179 PET: are both arterial blood sampling
and 90-min acquisitions essential? EJNMMI Res. 2018 Jun 11;8(1):46. doi:
10.1186/s13550-018-0396-2. PubMed PMID: 29892810; PubMed Central PMCID:
PMC5995767.


13: Hov KR, Neerland BE, Andersen AM, Undseth Ø, Wyller VB, MacLullich AMJ,
Skovlund E, Qvigstad E, Wyller TB. The use of clonidine in elderly patients with
delirium; pharmacokinetics and hemodynamic responses. BMC Pharmacol Toxicol. 2018
Jun 8;19(1):29. doi: 10.1186/s40360-018-0218-1. PubMed PMID: 29884231; PubMed
Central PMCID: PMC5994030.


14: Hynds RE, Gowers KHC, Nigro E, Butler CR, Bonfanti P, Giangreco A, Prêle CM,
Janes SM. Cross-talk between human airway epithelial cells and 3T3-J2 feeder
cells involves partial activation of human MET by murine HGF. PLoS One. 2018 May
17;13(5):e0197129. doi: 10.1371/journal.pone.0197129. eCollection 2018. PubMed
PMID: 29771943; PubMed Central PMCID: PMC5957441.


15: Siegel J, Záruba K, Švorčík V, Kroumanová K, Burketová L, Martinec J.
Round-shape gold nanoparticles: effect of particle size and concentration on
Arabidopsis thaliana root growth. Nanoscale Res Lett. 2018 Apr 10;13(1):95. doi:
10.1186/s11671-018-2510-9. PubMed PMID: 29637317; PubMed Central PMCID:
PMC5893504.


16: Ferguson KJ, Cvoro V, MacLullich AMJ, Shenkin SD, Sandercock PAG, Sakka E,
Wardlaw JM. Visual Rating Scales of White Matter Hyperintensities and Atrophy:
Comparison of Computed Tomography and Magnetic Resonance Imaging. J Stroke
Cerebrovasc Dis. 2018 Jul;27(7):1815-1821. doi:
10.1016/j.jstrokecerebrovasdis.2018.02.028. Epub 2018 Mar 23. PubMed PMID:
29576397; PubMed Central PMCID: PMC6013276.


17: Hynds RE, Ben Aissa A, Gowers KHC, Watkins TBK, Bosshard-Carter L, Rowan AJ,
Veeriah S, Wilson GA, Quezada SA, Swanton C; TRACERx Consortium, Janes SM.
Expansion of airway basal epithelial cells from primary human non-small cell lung
cancer tumors. Int J Cancer. 2018 Jul 1;143(1):160-166. doi: 10.1002/ijc.31383.
Epub 2018 Apr 6. PubMed PMID: 29569246; PubMed Central PMCID: PMC5969061.


18: Pariante CM. Too Much Is Still Not Enough, When Talking About Cortisol. Biol
Psychiatry Cogn Neurosci Neuroimaging. 2018 Mar;3(3):207-208. doi:
10.1016/j.bpsc.2018.01.012. PubMed PMID: 29486860.


19: Shenkin SD, Fox C, Godfrey M, Siddiqi N, Goodacre S, Young J, Anand A, Gray
A, Smith J, Ryan T, Hanley J, MacRaild A, Steven J, Black PL, Boyd J, Weir CJ,
MacLullich AM. Protocol for validation of the 4AT, a rapid screening tool for
delirium: a multicentre prospective diagnostic test accuracy study. BMJ Open.
2018 Feb 10;8(2):e015572. doi: 10.1136/bmjopen-2016-015572. PubMed PMID:
29440152; PubMed Central PMCID: PMC5879933.


20: Davis D, Richardson S, Hornby J, Bowden H, Hoffmann K, Weston-Clarke M, Green
F, Chaturvedi N, Hughes A, Kuh D, Sampson E, Mizoguchi R, Cheah KL, Romain M,
Sinha A, Jenkin R, Brayne C, MacLullich A. The delirium and population health
informatics cohort study protocol: ascertaining the determinants and outcomes
from delirium in a whole population. BMC Geriatr. 2018 Feb 9;18(1):45. doi:
10.1186/s12877-018-0742-2. PubMed PMID: 29426299; PubMed Central PMCID:
PMC5807842.